Major US health systems expect to offer Alzheimer’s drug Leqembi in a few months

By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) – Five major U.S. health systems said they would offer Eisai and Biogen’s promising new Alzheimer’s drug Leqembi after working out payment and administrative policies, and how to assess and monitor patients, most likely in the next month or two. Leqembi, which won full U.S. regulatory approval…

Read More

Biden vowed to reform immigration detention. Instead, private prisons benefited

By Ted Hesson, Mica Rosenberg and Kristina Cooke PHILIPSBURG, Pennsylvania (Reuters) – As a presidential candidate in 2020, Joe Biden pledged to end for-profit immigration detention, saying: “No business should profit from the suffering of desperate people fleeing violence.” The opportunity for action came early in the Democratic president’s term, in May 2021, when a…

Read More

S&P 500 quarterly earnings have been upbeat; revenue not so much

By Noel Randewich (Reuters) – S&P 500 companies have been reporting upbeat bottom lines for the June quarter, but not such impressive increases in their revenue. With second-quarter reporting season nearly complete, 79% of companies have posted earnings that beat analysts’ expectations, according to fresh data from Refinitiv I/B/E/S. In a typical U.S. earnings season,…

Read More

Record flooding along Alaska river near Juneau prompts evacuations

(Reuters) – Record flooding struck Alaska’s capital city on Saturday after a glacial dam outburst, destroying at least one structure and prompting city officials to issue evacuation orders for residents on one street. The National Weather Service (NWS) received reports of large trees collapsing into the Mendenhall River near Juneau on Saturday night as water…

Read More